Our Leading Parteners
In the field of synthetic biology and engineered probiotics, a chassis strain is more than just a microbial host—it's the foundational platform on which entire biological systems are built. Whether you're engineering pathways for biomanufacturing, expressing therapeutic proteins, or optimizing live biotherapeutics, the choice and design of a chassis strain directly impacts your project's efficiency, scalability, safety, and regulatory compliance.
At Creative Biolabs, we specialize in precision chassis strain development, offering tailor-made solutions that integrate in silico design, genome editing, metabolic rewiring, and high-throughput screening to support diverse applications—from R&D to industrial manufacturing.
Fig.1 Chassis strain selection with endogenously expressed OTS1
Biosynthetic capacity, secretion ability, post-translational modification needs
Presence or engineering of key enzymes, precursors, and cofactor pathways
Resistance to solvents, acids, temperature, pH, or high salt conditions
CRISPR, recombination, synthetic promoter compatibility
Maintenance of foreign constructs during fermentation
GRAS status, endotoxin risk, antibiotic resistance marker profiles
A fast-growing and genetically tractable Gram-negative bacterium, E. coli is widely used for recombinant protein expression, metabolite biosynthesis, and synthetic circuit testing. It supports a vast toolbox of promoters, vectors, and gene-editing systems.
As a GRAS-status eukaryotic yeast, S. cerevisiae is ideal for producing proteins requiring complex folding or glycosylation. It offers robust fermentation performance and is extensively used in food, pharma, and bioethanol industries.
This Gram-positive, spore-forming bacterium is ideal for secreting enzymes and other proteins directly into the medium. Its lack of endotoxins and ability to grow in simple media make it attractive for industrial enzyme manufacturing.
Common probiotic strains like Lactobacillus acidophilus are natural inhabitants of the gut and possess excellent safety profiles. Engineered Lactobacillus strains are used in functional food, live biotherapeutics, and microbiome modulation.
A robust industrial chassis for amino acid and organic acid production, C. glutamicum is non-pathogenic and offers stable, high-yield biosynthetic capabilities under aerobic conditions with low nutritional requirements.
Anaerobic bacteria such as Clostridium butyricum are useful for producing solvents, butyrate, and hydrogen gas. Their unique metabolism enables substrate flexibility and performance in oxygen-free fermentation systems.
A model fission yeast used in advanced eukaryotic studies, S. pombe supports precise control over cell cycle, transcriptional regulation, and epigenetics. It is gaining traction in biosynthetic and pharmaceutical applications.
Known for horizontal gene transfer in plants, A. tumefaciens is also being explored as a versatile chassis in plant synthetic biology and conjugative expression systems due to its natural transformation efficiency.
Known for its high cell density cultivation and strong, methanol-inducible promoters, P. pastoris excels in secreting heterologous proteins with minimal background. It is widely applied in enzyme, vaccine, and biologic production.
These soil-dwelling actinobacteria are famous for their secondary metabolite capacity, particularly antibiotics and polyketides. They serve as powerful hosts for heterologous expression of complex natural product pathways.
Our computational tools guide strain engineering by simulating key biological parameters:
These simulations reduce design uncertainty and focus lab work on the most promising strategies.
Multiwell plate fermentation
Advanced screening systems enable rapid iteration and selection of elite strains:
This integrated workflow shortens development cycles from months to weeks—delivering data-driven, scalable microbial chassis ready for production.
Creative Biolabs’ chassis strain services support a wide spectrum of synthetic biology and probiotic pipelines:
To ensure that your engineered chassis performs well not only in the lab but also in real-world production, Creative Biolabs offers full-spectrum fermentation support—from early-stage feasibility to pilot and industrial-scale implementation. We tailor our fermentation processes to each strain's physiological characteristics and your product's technical specifications.
Whether you're validating multiple clones, optimizing yields, or preparing for tech transfer, our platform ensures smooth scale-up with minimal rework.
Scale | Typical Volume | Service Highlights |
---|---|---|
Lab-Scale | 5–20 L | Proof-of-concept validation, batch reproducibility testing, clone screening |
Bench to Pilot | 20–200 L | Process optimization, feeding strategy design, and initial scale-up studies |
Pilot-Scale | 200–1000 L | Parameter refinement, production condition testing, cost-performance evaluation |
Industrial-Scale | >1000 L | Bulk fermentation, lot-to-lot consistency checks, raw material and input/output yield balance |
Our experienced team supports both aerobic and anaerobic fermentation, across bacteria, yeast, and fungal platforms. We also assist with strain stability assessments, medium optimization, and scale-up risk mitigation strategies.
Whether you're developing next-generation probiotics or optimizing microbial factories for sustainable biomanufacturing, Creative Biolabs is your trusted partner for chassis strain development. Request a quote now or talk to our experts to design your custom microbial chassis solution.
Chassis selection depends on product type, pathway compatibility, stress tolerance, genetic tractability, and scale-up feasibility. Our team evaluates these factors to match your specific production goals.
Yes. We apply advanced genome editing and pathway optimization to boost metabolic flux, reduce by-products, and increase titer.
Absolutely. We engineer strains with customized substrate pathways and environmental resilience.
Fully synthetic chassis allow for minimal genomes, expanded codons, and orthogonal control systems, offering higher biosafety, metabolic efficiency, and design flexibility for novel biosynthetic pathways.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.